Session » Reproductive Issues in Rheumatic Disorders Poster

10:30AM-12:30PM

Abstract Number: 0448

A Pregnant Lupus Patient’s Journey: Single-Center Outcomes and Opportunities

10:30AM-12:30PM

Abstract Number: 0441

A Qualitative Improvement Project to Incorporate the Mycophenolate Risk Evaluation and Mitigation Strategies in an Academic Lupus Clinic

10:30AM-12:30PM

Abstract Number: 0442

Anti-U1-RNP Related Pregnancy Loss in Systemic Lupus Erythematosus

10:30AM-12:30PM

Abstract Number: 0427

Association of Menopause and Systemic Rheumatic Disease Severity in Peri-Menopausal and Menopausal Women with Systemic Rheumatic Disease

10:30AM-12:30PM

Abstract Number: 0430

Clues from Early Gestational Mean Arterial Pressure in Predicting Preeclampsia Risk in Systemic Lupus Erythematosus (SLE)

10:30AM-12:30PM

Abstract Number: 0439

Contraception Counseling and Contraception Use Among SLE and RA/JIA Patients at a Public Medical Center in Los Angeles: Investigating Teratogenic Medication Use and Language Preferences

10:30AM-12:30PM

Abstract Number: 0455

Contraception Counseling for Patients with Rheumatic and Musculoskeletal Diseases (RMDs) at a Tertiary Care Rheumatology Clinic: A Quality Improvement Project

10:30AM-12:30PM

Abstract Number: 0417

Contraception in Community Rheumatology Practices

10:30AM-12:30PM

Abstract Number: 0444

Deep Serologic Profiling Identifies Novel Autoantibodies Associated with Fetal Atrioventricular Block

10:30AM-12:30PM

Abstract Number: 0437

Describing Maternal Outcomes Among Veterans with a History of Systemic Lupus Erythematosus and Rheumatoid Arthritis

10:30AM-12:30PM

Abstract Number: 0432

Disease Activity During Pregnancy in Patients with Rheumatoid Arthritis or Spondyloarthritis: Results from the Multicentre Prospective GR2 Study

10:30AM-12:30PM

Abstract Number: 0445

Evaluating Clinical Reasoning in Randomized Surveys of Lupus Nephritis and Preeclampsia Pregnancy Case Workups: A Clinical Conundrum

10:30AM-12:30PM

Abstract Number: 0449

Evaluating Premenstrual Dysphoric Disorder in Women with Rheumatoid Arthritis and Healthy Female Subjects

10:30AM-12:30PM

Abstract Number: 0454

Evaluating the Rate of Cervical Cancer Screening and HPV Vaccination in Women with Systemic Lupus Erythematosus Within a Large Urban Healthcare System

10:30AM-12:30PM

Abstract Number: 0429

Exploring the Impact of Autoimmune Rheumatic Diseases on Human Milk Macronutrient Composition

10:30AM-12:30PM

Abstract Number: 0420

Factors Associated with Infant Feeding Behaviors Among Women with Systemic Rheumatic Diseases

10:30AM-12:30PM

Abstract Number: 0436

Family Planning in Rheumatology: A Single Center Quality Improvement Project

10:30AM-12:30PM

Abstract Number: 0422

Greater Use of Assisted Reproductive Techniques but Comparable Obstetric Morbidity in a Population of Women with Spondyloarthritis: A Matched Comparative Analysis of the GR2 Prospective Cohort and the French National Perinatal Surveys

10:30AM-12:30PM

Abstract Number: 0423

Higher Risk of Preterm Delivery in Women with Rheumatoid Arthritis: A Matched Comparative Analysis of the GR2 Prospective Cohort and the French National Perinatal Surveys

10:30AM-12:30PM

Abstract Number: 0418

Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice

10:30AM-12:30PM

Abstract Number: 0450

Knowledge, Attitudes, and Intention Towards HPV Vaccination Among Reproductive-Age Women with Rheumatic Diseases

10:30AM-12:30PM

Abstract Number: 0451

Macrophages and Interferon Upregulation in Placentas from Patients with Systemic Lupus Erythematosus, Primary Sjögren’s Disease and Antiphospholipid Syndrome

10:30AM-12:30PM

Abstract Number: 0433

Male Perspective on Reproductive Health in Rheumatology Patients: A Cross-sectional Study

10:30AM-12:30PM

Abstract Number: 0438

Overweight and Obesity Are Key Modifiable Risk Factors for Adverse Outcomes in SLE Pregnancies

10:30AM-12:30PM

Abstract Number: 0428

Placental Characteristics in Systemic Lupus Erythematosus Pregnancies Resulting in Small for Gestational Age Infants

10:30AM-12:30PM

Abstract Number: 0419

Placental Weights of Offspring Born to Women with Rheumatoid Arthritis and Juvenile Idiopathic Arthritis

10:30AM-12:30PM

Abstract Number: 0440

Pregnancy Outcome Disparities Among Women with Systemic Lupus Erythematosus

10:30AM-12:30PM

Abstract Number: 0447

Pregnancy Outcomes in Women Exposed to Guselkumab: Review of Cases Reported to the Manufacturer’s Global Safety Database

10:30AM-12:30PM

Abstract Number: 0434

Pregnancy Outcomes of Biosimilars and Non-TNF Inhibitor Biologic Disease-Modifying Antirheumatic Drugs: A Scoping Review

10:30AM-12:30PM

Abstract Number: 0426

Quality Improvement Initiative to Increase Contraception Screening and Documentation for Reproductive-Aged Women Prescribed Teratogenic Medications in an Academic Rheumatology Center

10:30AM-12:30PM

Abstract Number: 0431

Reproductive Health in Women with Rheumatic Diseases: Knowledge and Behaviors

10:30AM-12:30PM

Abstract Number: 0452

Reproductive Health Needs of Women with Rheumatic Disease: An EMR-Based Online Survey Study

10:30AM-12:30PM

Abstract Number: 0446

Rheum for Improvement: Contraception Counseling and Adherence in Patients with Lupus and Rheumatoid Arthritis on Teratogenic Medications

10:30AM-12:30PM

Abstract Number: 0453

Risk of Active Disease Determines the Expert Opinion Use of Biologics in Pregnancy, but Less in Breastfeeding, and in Men Planning a Family

10:30AM-12:30PM

Abstract Number: 0443

Significance of anti-Ro52 Antibody in Pregnancy Complicated with Anti-SS-A Antibody Positive Rheumatic Disease Patients

10:30AM-12:30PM

Abstract Number: 0424

The Clinical Utility of Serum BAFF Levels in Pregnant Patients with SLE

10:30AM-12:30PM

Abstract Number: 0421

The Effect of Biologic Treatment for Psoriatic Arthritis and Axial Spondyloarthritis on Semen Parameters – a Longitudinal Study

10:30AM-12:30PM

Abstract Number: 0425

Use of bDMARDs During Pregnancy After Preconceptional Counseling in Spanish Patients with Rheumatic Diseases

10:30AM-12:30PM

Abstract Number: 0435

Use of Contraception in Women of Childbearing Age with Immune-Mediated Rheumatic Diseases: Experience from an Italian Centre